Home › Entities › clinical_trial › MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

clinical trial
MedicalStudy clinical_trial Q65361671
Press Enter · cited answer in seconds

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Summary

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial is a clinical trial[1].

Key Facts

  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial is in the country of Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — country (P17): United Kingdom[2].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's instance of is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — instance of (P31): clinical trial[3].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's start time is recorded as +2014-12-18T00:00:00Z[4].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's end time is recorded as +2018-07-31T00:00:00Z[5].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's contributor to the creative work or subject is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — contributor to the creative work or subject (P767): Queen Mary University of London[6].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's contributor to the creative work or subject is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — contributor to the creative work or subject (P767): University of Sheffield[7].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's main subject is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — main subject (P921): multiple sclerosis[8].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's main subject is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — main subject (P921): sclerosis[9].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's number of participants is recorded as {'unit': '1', 'amount': '+445'}[10].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's title is recorded as A Multi-arm Phase IIB Randomised, Double Blind Placebo-controlled Clinical Trial Comparing the Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis.[11].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's short name is recorded as MS-SMART[12].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+25'}[13].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's ClinicalTrials.gov ID is recorded as NCT01910259[14].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[15].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's research intervention is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — research intervention (P4844): fluoxetine[16].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's research intervention is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — research intervention (P4844): amiloride[17].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's clinical trial phase is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — clinical trial phase (P6099): phase II clinical trial[18].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's research site is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — research site (P6153): Walton Centre[19].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's research site is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — research site (P6153): Queen's Medical Centre[20].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's research site is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — research site (P6153): Derriford Hospital[21].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's research site is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — research site (P6153): Royal Hallamshire Hospital[22].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's research site is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — research site (P6153): Keele University Students' Union[23].
  • MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial's study type is recorded as Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — study type (P8363): interventional study[24].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.
  21. [22] ↑ . wikidata.org.
  22. [23] ↑ . wikidata.org.
  23. [24] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial. Retrieved May 3, 2026, from https://4ort.xyz/entity/ms-smart-multiple-sclerosis-secondary-progressive-multi-arm-randomisation-trial
MLA “MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/ms-smart-multiple-sclerosis-secondary-progressive-multi-arm-randomisation-trial.
BibTeX @misc{4ortxyz_ms-smart-multiple-sclerosis-secondary-progressive-multi-arm-randomisation-trial_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial}}, year = {2026}, url = {https://4ort.xyz/entity/ms-smart-multiple-sclerosis-secondary-progressive-multi-arm-randomisation-trial}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial — https://4ort.xyz/entity/ms-smart-multiple-sclerosis-secondary-progressive-multi-arm-randomisation-trial (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/ms-smart-multiple-sclerosis-secondary-progressive-multi-arm-randomisation-trial · Last refreshed: